Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elicio Therapeutics (ELTX) Cash from Financing Activities (2020 - 2026)

Elicio Therapeutics filings provide 4 years of Cash from Financing Activities readings, the most recent being $7.0 million for Q4 2023.

  • On a quarterly basis, Cash from Financing Activities fell 37.36% to $7.0 million in Q4 2023 year-over-year; TTM through Dec 2023 was $38.6 million, a 82.12% increase, with the full-year FY2025 number at $36.7 million, down 13.29% from a year prior.
  • Cash from Financing Activities hit $7.0 million in Q4 2023 for Elicio Therapeutics, up from $60000.0 in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $108.4 million in Q1 2021 to a low of -$2.4 million in Q2 2021.
  • Median Cash from Financing Activities over the past 4 years was $5.5 million (2020), compared with a mean of $13.7 million.
  • Biggest five-year swings in Cash from Financing Activities: tumbled 113.93% in 2021 and later soared 71814.29% in 2023.
  • Elicio Therapeutics' Cash from Financing Activities stood at $202000.0 in 2020, then skyrocketed by 100.0% to $404000.0 in 2021, then surged by 2666.34% to $11.2 million in 2022, then crashed by 37.36% to $7.0 million in 2023.
  • The last three reported values for Cash from Financing Activities were $7.0 million (Q4 2023), $60000.0 (Q3 2023), and $21.5 million (Q2 2023) per Business Quant data.